Dr. Reddy’s Laboratories Limited reported Total Income for Q4 FY23 of ₹6,453.7 Crore up from ₹5,596.8 Crore year on year, a growth of 15.3%. Consolidated Net Profit of ₹960.1 Crore, surged from ₹97 Crore in the same quarter of the previous year. The Earnings per Share is ₹57.68, from ₹5.83 in the same quarter of the previous year.
Dr Reddy’s Laboratories Q4 FY23; Net Profit Surged Up To ₹960 Crore
Tags: pharmaceuticals
Related Post
- Titan Company Ltd Q2FY25; 1.5% fall in Net Profits
Company Overview: Titan Company Ltd is among India’s most respected lifestyle companies. It has established…
-
Coal India Ltd Q2FY25; 22% fall in Profits
Coal India Ltd is mainly engaged in mining and production of Coal and also operates…
-
Cholamandalam Investment & Finance Company Ltd Q2FY25; 25% rise in Profits
Cholamandalam Investment & Finance Company is one of the premier diversified non-banking finance companies in…